Φορτώνει......
Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus
Exenatide is a GLP-1 analogue used in the management of T2DM yet within a subset of patients fails due to adverse side effects or from failure to attain the end goal. This retrospective observational study aimed to determine whether we could predict response to exenatide in patients with T2DM. 112 p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Diabetes Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Hindawi Publishing Corporation
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4320857/ https://ncbi.nlm.nih.gov/pubmed/25688374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/162718 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|